AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 81 filers reported holding AVADEL PHARMACEUTICALS PLC in Q3 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $206 | +33.8% | 20,047 | +19.6% | 0.02% | +25.0% |
| Q1 2023 | $154 | +40.0% | 16,759 | +9.5% | 0.02% | +6.7% |
| Q4 2022 | $110 | -99.8% | 15,310 | +45.2% | 0.02% | +200.0% |
| Q3 2022 | $53,000 | -74.1% | 10,541 | -58.5% | 0.01% | -76.2% |
| Q4 2021 | $205,000 | +111.3% | 25,427 | +75.8% | 0.02% | +110.0% |
| Q4 2020 | $97,000 | -63.7% | 14,461 | -56.2% | 0.01% | -67.7% |
| Q2 2020 | $267,000 | +151.9% | 33,048 | +155.0% | 0.03% | +416.7% |
| Q4 2017 | $106,000 | -23.7% | 12,959 | -1.9% | 0.01% | -14.3% |
| Q3 2017 | $139,000 | – | 13,208 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ACUTA CAPITAL PARTNERS, LLC | 1,625,000 | $12,269,000 | 3.04% |
| GENDELL JEFFREY L | 1,146,764 | $8,658,000 | 1.11% |
| Broadfin Capital, LLC | 1,029,012 | $7,769,000 | 1.04% |
| RTW INVESTMENTS, LP | 3,401,434 | $25,681,000 | 0.97% |
| BRANDES INVESTMENT PARTNERS, LP | 3,651,948 | $27,571,000 | 0.66% |
| Aristides Capital LLC | 71,520 | $540,000 | 0.42% |
| Tekla Capital Management LLC | 814,588 | $6,150,000 | 0.23% |
| INVESTORS ASSET MANAGEMENT OF GEORGIA INC /GA/ /ADV | 36,100 | $273,000 | 0.17% |
| Leap Investments LP | 43,481 | $328,000 | 0.15% |
| Brown Capital Management | 1,829,886 | $13,816,000 | 0.13% |